Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Axovant Sciences Ltd. | 42,000 | reported | 15 Apr 2021 | tx 3+78,250 |
| Terns Pharmaceuticals, Inc. | 9,770 | reported | 31 May 2023 | tx 6+1,504,770 |
| Nightstar Therapeutics plc | 0 | reported | 07 Jun 2019 | tx 6+108,700−296,383 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 31 May 2023 | PURCHASE | Terns Pharmaceuticals, Inc. | 2,111 | 1.41 USD | |
| 30 Nov 2022 | PURCHASE | Terns Pharmaceuticals, Inc. | 3 | 1.41 USD | |
| 01 Feb 2023 | GRANT_AWARD | Terns Pharmaceuticals, Inc. | 900,000 | 0.00 USD | deriv |
| 31 May 2022 | PURCHASE | Terns Pharmaceuticals, Inc. | 7,656 | 1.47 USD | |
| 26 Jan 2022 | GRANT_AWARD | Terns Pharmaceuticals, Inc. | 280,000 | 0.00 USD | deriv |
| 28 Sept 2021 | GRANT_AWARD | Terns Pharmaceuticals, Inc. | 315,000 | 0.00 USD | deriv |
| 15 Apr 2021 | GRANT_AWARD | Axovant Sciences Ltd. | 42,000 | 0.00 USD | deriv |
| 15 Apr 2020 | GRANT_AWARD | Axovant Sciences Ltd. | 17,500 | 0.00 USD | deriv |
| 27 Jun 2019 | GRANT_AWARD | Axovant Sciences Ltd. | 18,750 | 0.00 USD | deriv |
| 07 Jun 2019 | OTHER | Nightstar Therapeutics plc | 126,886 | 25.50 USD | |
| 07 Jun 2019 | OTHER | Nightstar Therapeutics plc | 60,000 | 11.26 USD | deriv |
| 07 Jun 2019 | OTHER | Nightstar Therapeutics plc | 108,700 | 10.76 USD | deriv |
| 01 Apr 2019 | SALE | Nightstar Therapeutics plc | 391 | 25.31 USD | |
| 22 Jan 2019 | GRANT_AWARD | Nightstar Therapeutics plc | 108,700 | 0.00 USD | deriv |
| 07 Jan 2019 | SALE | Nightstar Therapeutics plc | 406 | 12.98 USD |